DRKS00011249已完成未知
Prospective, randomized, controlled, Investigator Initiated Study to investigate Efficacy and Safety of cell-free Autologous Conditioned Serum (ACS) alone or in combination with hyaluronic acid (HA) in reduced facial skin elasticity by woman - OrthoSkin2
niversität Hamburg Fachrichtung Kosmetikwissenschaft0 个研究点目标入组 42 人开始时间: 2016年11月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 42
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 35 Years 至 65 Years（—）
- 性别
- Female
入选标准
- •1. Provision of signed and dated informed consent form to participate in the study
- •2. Non-pregnant female aged 35-65 years
- •3. High loss of facial skin elasticity according to the Investigator’s opinion
排除标准
- •1. Severe skin diseases e.g. psoriasis, atopic eczema (neurodermatitis) or other autoimmune skin diseases
- •2. Skin cancer in the anamnesis
- •3. Systemic diseases with skin involvement (SLE)
- •4. Pre-treatment with laser, botox or hyaluronic acid in the tested face area (treatment areal)
- •5. Severe diet in the last 3 months or nutritional
- •supplementary during the last 3 years
- •6. Acute infection
- •7. Chronic acne
研究者
相似试验
进行中（未招募）
1 期
Prospective, controlled, randomized, investigator-masked, multicenter, phase III trial In this trial, data to demonstrate the efficacy and safety of Brimonidine UD is generated. Subjects either use Brimonidine UD or a control drug. The drugs are assigned randomly. The investigators generating the data are not aware of which drug a subject they are treating received. Investigations are carried out at multiple trial sites (doctor’s offices or hospitals).EUCTR2015-001489-24-DEPharma Stulln GmbH
终止
不适用
A randomised controlled trial of a non-invasive injection site desensitiser device for use in blood donation. Part 2: EfficacyBlood DonationACTRN12618000099224Australian Red Cross Blood Service450
已完成
4 期
Feasibility and Efficacy of using a non-invasive pain numbing device in Australian Blood Donor Centres - Part 1Blood DonationACTRN12617000950369Australian Red Cross Blood Service50
进行中（未招募）
不适用
A prospective, randomized, investigator-blind, controlled, clinical study of phase III on the clinical efficacy and tolerability of hMG-IBSA IBSA Institut Biochimique sa versus Menopur Ferring administered subcutaneously in women undergoing controlled ovarian hyperstimulation COH in an ART programme IVF .EUCTR2005-000993-29-ITIBSA
尚未招募
不适用
A comparative clinical study to evaluate the efficacy of Nixiyax on mental wellbeing in subjects with acne problemsCTRI/2019/01/017172Curatio Healthcare I Pvt Ltd